✦ LIBER ✦

Increasing recognition of corticosteroid-induced tumor lysis syndrome in non-Hodgkin's lymphoma

✍ Scribed by Joseph Sparano; Mark Ramirez; Peter H. Wiernik

Publisher: John Wiley and Sons
Year: 1990
Tongue: English
Weight: 185 KB
Volume: 65
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19900301)65:5<1072::aid-cncr2820650504>3.0.co;2-a

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acute tumor lysis syndrome in non-Hodgki

Acute tumor lysis syndrome in non-Hodgkin lymphoma induced by dexamethasone

✍ Kapil Dhingra; Dr. Samuel R. Newcom 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 2 views

Multiple recurrences of acute tumor lysi

Multiple recurrences of acute tumor lysis syndrome in an indolent non-hodgkin's lymphoma

✍ Ralph V. Boccia; Dan L. Longo; Michael L. Lieber; Elaine S. Jaffe; Richard I. Fi 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 367 KB 👁 2 views

Tumor lysis syndrome in a case of chroni

Tumor lysis syndrome in a case of chronic lymphocytic leukemia induced by high-dose corticosteroids

✍ Coutinho, Anelisa K.; Santos, Marcelo de O.; Pinczowski, Hélio; Feher, Olavo; de 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB 👁 2 views

To the Editor: Schwachman's syndrome, a familial disease transmitted as an autosomal-recessive trait, is characterized by moderate chronic neutropenia, marked marrow hypocellularity, occasional thrombocytopenia and anemia, metaphyseal dysostosis of tubular bones, pancreatic fatty infiltration, and a

Tumor lysis syndrome occurring after the

Tumor lysis syndrome occurring after the administration of rituximab in lymphoproliferative disorders: High-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia

✍ Yang, Honghao; Rosove, Michael H.; Figlin, Robert A. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 27 KB 👁 2 views

Rituximab, an anti-CD20 antibody, has been recently approved for the treatment of lowgrade or follicular non-Hodgkin's lymphoma (NHL). Because of its relatively benign side effect profile, it has been considered a nontoxic alternative to chemotherapy. Recently, however, tumor lysis syndrome (TLS) re

Increased levels of circulating interleu

Increased levels of circulating interleukin-6 in patients with newly diagnosed non-Hodgkin's lymphomas

✍ Roberto Stasi; Adriano Venditti; Giovanni Del Poeta; Marina Conforti; Ugo Coppet 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB 👁 1 views

Mutation of BAX occurs infrequently in a

Mutation of BAX occurs infrequently in acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas

✍ Gianluca Gaidano; Daniela Vivenza; Francesco Forconi; Daniela Capello; Annunziat 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 2 views

Acquired immunodeficiency syndrome (AIDS)-related non-Hodgkin's lymphomas (AIDS-NHLs) consistently derive from B cells, are histologically heterogeneous, and are associated with distinct molecular pathways depending upon histology. Recently, it has been proposed that inactivating mutations of the ba